Improving Stroke Care in North-Norway Through Artificial Intelligence
ConditionIschemic Stroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital of North Norway
About this trial
Prospective observational multi-center intervention study. The study aims to evaluate whether an artificial intelligence (AI) support tool for radiological image processing (StrokeSens, Circle NVI) can accelerate decision making and increase detection rate in patients with an acute ischemic stroke caused by intracranial large vessel occlusion (LVO) or medium vessel occlusion (MeVO) in Northern Norway. Relevant outcomes will be compared between centres with and without available software during the study period.
Eligibility criteria
Qualifiers
Patients with acute stroke symptoms admitted to a participating hospital within 24 hours of symptom onset
Disqualifiers
Patients not available for follow-up assessments (e.g. non-resident)
Trial design
Treatments tested in this trial
- AI software StrokeSens (Circle NVI)
Treatment groups
1,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
University Hospital of North Norway
Lead sponsor
Nordlandssykehuset HF
Collaborator
Helgeland Hospital Trust
Collaborator
Finnmarkssykehuset HF
Collaborator
Oslo University Hospital
Collaborator
Source ClinicalTrials.gov